Slideshows

1H R&D for Pharma and Biopharma

Merck, BMS, Biogen and others see a significant decline in expenses

By: Kristin Brooks

Managing Editor, Contract Pharma


 

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters